CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ITHACA develops a personalized medicine toolkit for ovarian cancer treatment. It utilizes advanced computational simulations and in-vitro techniques to identify the most effective therapies for individual patients, enhancing treatment personalization and optimizing outcomes.
Personalised medicine (PM) is a novel approach to medical care that customises each treatment not just to the disease but also to the patient.
While the advantages of this framework are widely recognised and its development is acknowledged as a fundamental societal challenge by the H2020 program, clinical applications are still limited, due to the increased complexity and costs, with respect to the current standard of care. ITHACA aims at developing an innovative PM toolkit that, relying on an…
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Australia, Sydney
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.